Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-25T19:12:02.693Z Has data issue: false hasContentIssue false

Adrenoceptor activity and adenylate cyclase inhibition in depression

Published online by Cambridge University Press:  02 January 2018

M. T. Abou-Saleh
Affiliation:
Department of Psychiatry and Behavioural Sciences, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, UAE
J. Collins
Affiliation:
Department of Psychiatry, Royal Liverpool, Hospital
A. George
Affiliation:
Department of Psychiatry, Royal Liverpool, Hospital
Hans Rommelspacher
Affiliation:
Institute of Neuropsychopharmacology, Berlin
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1994 

References

Collins, J. & Abou-Saleh, M. T. (1992) Rolipram: a new concept for the treatment of tricyclic resistant depression. Journal of Drug Development, 5, 6570.Google Scholar
Doyle, M., George, A. J., Ravindran, R., et al (1985) Platelet α2 adrenoceptor activity in dementia. American Journal of Psychiatry, 142, 14891491.Google Scholar
Schultz, J. E., Uhl, D. G. & Klump, S. (1987) Adenylate cyclase bioassay. Journal of Biochemistry, 246, 187192.Google Scholar
Siever, L. J., Kafka, M. S., Targum, S., et al (1984) Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Research, 11, 287302.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.